Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework

MJ Akiyama, N Kronfli, J Cabezas… - The lancet …, 2021 - thelancet.com
Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …

[PDF][PDF] Key elements on the pathway to HCV elimination: lessons learned from the AASLD HCV special interest group 2020

JJ Feld, JW Ward - Hepatology Communications, 2021 - Wiley Online Library
With a decade left to reach the ambitious goals for viral hepatitis elimination set out by the
World Health Organization, many challenges remain. Despite the remarkable improvements …

Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting

A Cuadrado, C Cobo, M Mateo, AJ Blasco… - International Journal of …, 2021 - Elsevier
Introduction Linkage to care for hepatitis C includes a new tool: teleconsultation. Micro-
elimination in prison is a recommendation and is feasible. An economic evaluation of …

[HTML][HTML] Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative …

AS Ruiz, G Fontaine, AM Patey, JM Grimshaw… - International Journal of …, 2022 - Elsevier
Background Diffuse implementation of hepatitis C virus (HCV) treatment is dependent on
universal screening for HCV, but screening strategies are heterogenous across prisons in …

[PDF][PDF] Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct‐Acting Antiviral …

SR Bartlett, J Buxton, A Palayew… - Clinical Liver …, 2021 - Wiley Online Library
Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated
in Canada: Leaving No One Behind in the Page 1 75 | CliniCal liver Disease, vOl 17, nO 2 …

[HTML][HTML] HCV treatment initiation in the era of universal direct acting antiviral coverage–Improvements in access and persistent barriers

N Jiang, J Bruneau, I Makarenko, N Minoyan… - International Journal of …, 2023 - Elsevier
Background Barriers to HCV treatment initiation persisted after the introduction of direct-
acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA …

Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: a model-based cost-effectiveness analysis

L Duchesne, C Dussault, A Godin… - International Journal of …, 2021 - Elsevier
Background Implementing opt-out hepatitis C virus (HCV) screening across Canadian
provincial prisons is crucial to achieving micro-elimination. Given short incarceration …

Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination

STF Shih, J Stone, NK Martin… - Open Forum …, 2024 - academic.oup.com
Abstract Background The Surveillance and Treatment of Prisoners With Hepatitis C (SToP-
C) study demonstrated that scaling up of direct-acting antiviral (DAA) treatment reduced …

[HTML][HTML] A new collaborative care approach toward hepatitis C elimination in marginalized populations

WW Su, CC Yang, RWJ Chang, YH Yeh… - Journal of Infection and …, 2023 - Elsevier
Background Treating marginalized populations with HCV infection for elimination is faced
with the challenge for the integration of HCV screening service offered for patients often …

[HTML][HTML] Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening

AH Çekin, R Güner, AÇ İnkaya, D Oğuz… - The Turkish Journal …, 2023 - ncbi.nlm.nih.gov
Materials and Methods: A Markov model was used to analyze and compare regular care
with a scenario developed by experts including the screening and treatment of all acute and …